Only One in Four High-Risk Rural Births Get Appropriate Hospital Care
A Multi-State Study Finds That Parents Often Travel 60+ Miles—With Distance, Insurance, and Race Driving Gaps in Maternal Care
Research & Policy Updates
Inside Medicare’s Stalled Shift to Value-Based Care
Former CMMI Leader Liz Fowler Cites Rigid Federal Scoring Rules and Bureaucratic Impatience for Pilot Failures
How Hospitals Can Ease Staff Burnout—and Improve Patient Safety
A Major European–U.S. Hospital Study Finds That Changing How Hospitals Are Organized Reduces Burnout and Turnover While Improving Care Quality
Center for Medicare and Medicaid Services: A Notable Success in Trump 2.0
An LDI Fellow Who Helped Architect the ACA Highlights Progress on Primary Care Payment Reform and the Expansion of Site-Neutral Reimbursement Policies
ED Psychiatric Boarding of Children Worsens Nationwide
Penn LDI Senior Fellow Dominic Sisti Cites “Alarming Levels"
Methadone Use Rises—But Too Few People Get Opioid Medication
Chart of the Day: Methadone Use for Opioid Use Disorder Tripled From 2010–2020, Yet Only One in Four People With Addiction Receive Medication
Can AI Hear When Patients Are Ready for Palliative Care?
Researchers Use AI to Analyze Patient Phone Calls for Vocal Cues Predicting Palliative Care Acceptance
Medicare’s Hidden Fix for High Drug Costs
Medicare’s Payment Plan Can Ease Seniors’ Crushing Drug Costs but Medicare Buries it in the Fine Print
Six Insights on Health Care Affordability From Penn LDI
LDI Fellows’ Research Quantifies the Effects of High Health Care Costs for Consumers and Shines Light on Several Drivers of High U.S. Health Care Costs
Medicare and Medicaid Programs; Repeal of Minimum Staffing Standards for Long-Term Care Facilities
Comment: Submitted to Centers for Medicare & Medicaid Services
Can AI Be Licensed the Way Doctors and Nurses Are?
A Licensure Model May Offer Safer Oversight as Clinical AI Grows More Complex, a Penn LDI Doctor Says
Venture Philanthropy Transformed Cystic Fibrosis. Can It Deliver for Other Diseases?
CF Foundation’s Landmark Drug Approvals With Vertex Inspired Patient Groups to Act Like Biotech Investors. But Only a Few Groups Have Made Big Bets, LDI Fellow Finds